Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report “Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

Esomeprazole Market Report Highlights

Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.

Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.

Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.

APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.

The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:

Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Capsules

Tablets

Injections

Others

Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Gastroesophageal reflux disease

Erosive Esophagitis

Peptic Ulcers

Duodenal Ulcers

Zollinger-Ellison Syndrome

Others

Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

Hospitals & Clinical Pharmacies

Online Pharmacies

OTC

Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa